Duration of trastuzumab for HER2-positive breast cancer

被引：3

作者：

Montemurro, Filippo ^{[1
,2
]}

Aglietta, Massimo ^{[2
]}

机构：

[1] Inst Canc Res & Treatment, Piedmont Oncol Fdn, Unit Invest Clin Oncol, I-10060 Candiolo, Italy

[2] Inst Canc Res & Treatment, Piedmont Oncol Fdn, Div Med Oncol, I-10060 Candiolo, Italy

来源：

LANCET ONCOLOGY | 2013年 / 14卷 / 08期

关键词：

OPEN-LABEL; CHEMOTHERAPY; MULTICENTER; LAPATINIB;

D O I：

10.1016/S1470-2045(13)70273-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：678 / 679

页数：2

共 11 条

[1] Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial [J].

Baselga, Jose ;

Bradbury, Ian ;

Eidtmann, Holger ;

Di Cosimo, Serena ;

de Azambuja, Evandro ;

Aura, Claudia ;

Gomez, Henry ;

Dinh, Phuong ;

Fauria, Karine ;

Van Dooren, Veerle ;

Aktan, Gursel ;

Goldhirsch, Aron ;

Chang, Tsai-Wang ;

Horvath, Zsolt ;

Coccia-Portugal, Maria ;

Domont, Julien ;

Tseng, Ling-Min ;

Kunz, Georg ;

Sohn, Joo Hyuk ;

Semiglazov, Vladimir ;

Lerzo, Guillermo ;

Palacova, Marketa ;

Probachai, Volodymyr ;

Pusztai, Lajos ;

Untch, Michael ;

Gelber, Richard D. ;

Piccart-Gebhart, Martine .

LANCET, 2012, 379 (9816) :633-640

[2] Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial [J].

Gianni, Luca ;

Pienkowski, Tadeusz ;

Im, Young-Hyuck ;

Roman, Laslo ;

Tseng, Ling-Ming ;

Liu, Mei-Ching ;

Lluch, Ana ;

Staroslawska, Elzbieta ;

de la Haba-Rodriguez, Juan ;

Im, Seock-Ah ;

Pedrini, Jose Luiz ;

Poirier, Brigitte ;

Morandi, Paolo ;

Semiglazov, Vladimir ;

Srimuninnimit, Vichien ;

Bianchi, Giulia ;

Szado, Tania ;

Ratnayake, Jayantha ;

Ross, Graham ;

Valagussa, Pinuccia .

LANCET ONCOLOGY, 2012, 13 (01) :25-32

[3]

Goldhirsch A, LANCET IN PRESS

[4] Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer [J].

Johnston, Stephen ;

Pippen, John, Jr. ;

Pivot, Xavier ;

Lichinitser, Mikhail ;

Sadeghi, Saeed ;

Dieras, Veronique ;

Gomez, Henry Leonidas ;

Romieu, Gilles ;

Manikhas, Alexey ;

Kennedy, M. John ;

Press, Michael F. ;

Maltzman, Julie ;

Florance, Allison ;

O'Rourke, Lisa ;

Oliva, Cristina ;

Stein, Steven ;

Pegram, Mark .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) :5538-5546

[5] Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study [J].

Kaufman, Bella ;

Mackey, John R. ;

Clemens, Michael R. ;

Bapsy, Poonamalle P. ;

Vaid, Ashok ;

Wardley, Andrew ;

Tjulandin, Sergei ;

Jahn, Michaela ;

Lehle, Michaela ;

Feyereislova, Andrea ;

Revil, Cedric ;

Jones, Alison .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) :5529-5537

[6] Comprehensive molecular portraits of human breast tumours [J].

Koboldt, Daniel C. ;

Fulton, Robert S. ;

McLellan, Michael D. ;

Schmidt, Heather ;

Kalicki-Veizer, Joelle ;

McMichael, Joshua F. ;

Fulton, Lucinda L. ;

Dooling, David J. ;

Ding, Li ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

Ally, Adrian ;

Balasundaram, Miruna ;

Butterfield, Yaron S. N. ;

Carlsen, Rebecca ;

Carter, Candace ;

Chu, Andy ;

Chuah, Eric ;

Chun, Hye-Jung E. ;

Coope, Robin J. N. ;

Dhalla, Noreen ;

Guin, Ranabir ;

Hirst, Carrie ;

Hirst, Martin ;

Holt, Robert A. ;

Lee, Darlene ;

Li, Haiyan I. ;

Mayo, Michael ;

Moore, Richard A. ;

Mungall, Andrew J. ;

Pleasance, Erin ;

Robertson, A. Gordon ;

Schein, Jacqueline E. ;

Shafiei, Arash ;

Sipahimalani, Payal ;

Slobodan, Jared R. ;

Stoll, Dominik ;

Tam, Angela ;

Thiessen, Nina ;

Varhol, Richard J. ;

Wye, Natasja ;

Zeng, Thomas ;

Zhao, Yongjun ;

Birol, Inanc ;

Jones, Steven J. M. ;

Marra, Marco A. ;

Cherniack, Andrew D. ;

Saksena, Gordon ;

Onofrio, Robert C. ;

Pho, Nam H. .

NATURE, 2012, 490 (7418) :61-70

[7] Trastuzumab containing regimens for early breast cancer [J].

Moja, Lorenzo ;

Tagliabue, Ludovica ;

Balduzzi, Sara ;

Parmelli, Elena ;

Pistotti, Vanna ;

Guarneri, Valentina ;

D'Amico, Roberto .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04)

[8] Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients [J].

Montemurro, Filippo ;

Rossi, Valentina ;

Rocca, Maria Cossu ;

Martinello, Rossella ;

Verri, Elena ;

Redana, Stefania ;

Adamoli, Laura ;

Valabrega, Giorgio ;

Sapino, Anna ;

Aglietta, Massimo ;

Viale, Giuseppe ;

Goldhirsch, Aron ;

Nole, Franco .

CANCER, 2012, 118 (01) :17-26

[9] 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial [J].

Pivot, Xavier ;

Romieu, Gilles ;

Debled, Marc ;

Pierga, Jean-Yves ;

Kerbrat, Pierre ;

Bachelot, Thomas ;

Lortholary, Alain ;

Espie, Marc ;

Fumoleau, Pierre ;

Serin, Daniel ;

Jacquin, Jean-Philippe ;

Jouannaud, Christelle ;

Rios, Maria ;

Abadie-Lacourtoisie, Sophie ;

Tubiana-Mathieu, Nicole ;

Cany, Laurent ;

Catala, Stephanie ;

Khayat, David ;

Pauporte, Iris ;

Kramar, Andrew .

LANCET ONCOLOGY, 2013, 14 (08) :741-748

[10] Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: TBCRC 006 [J].

Rimawi, Mothaffar F. ;

Mayer, Ingrid A. ;

Forero, Andres ;

Nanda, Rita ;

Goetz, Matthew P. ;

Rodriguez, Angel A. ;

Pavlick, Anne C. ;

Wang, Tao ;

Hilsenbeck, Susan G. ;

Gutierrez, Carolina ;

Schiff, Rachel ;

Osborne, C. Kent ;

Chang, Jenny C. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (14) :1726-1731

← 1 2 →